Related Experiment Video
Updated: Jun 16, 2026
Transcranial Direct Current Stimulation tDCS in Mice
Published on: September 23, 2018
Minas Gerais Reference Center for Special Immunobiologicals: clinical and epidemiological profile (2005-2022)
Thaís Moreira Oliveira1, Ana Luiza Gomes Bragança1, Tatianne Márcia Perdigão de Carvalho Alcantara2
1a Universidade Federal de Minas Gerais, Escola de Enfermagem, Belo Horizonte, MG, Brasil.
Objective:
To analyze the clinical and epidemiological profile of remote consultations evaluated by the Reference Center for Special Immunobiologicals of Minas Gerais, Brazil, between 2005 and 2022.
Method:
Cross-sectional and retrospective study. Data collection was performed by extracting data from the request forms evaluated in virtual consultations. The statistical program Stata® was used for the analysis. Categorical variables were described using absolute and relative frequencies, and continuous variables were described using median and interquartile range.
Results:
Of the 84,800 forms evaluated, 32,750 individuals were eligible to receive special immunobiologicals, with 65,521 doses prescribed. Among these individuals, 11,505 (35.1%) were children, 1,943 (6.0%) were adolescents, 12,024 (36.7%) were adults, and 7,278 (22.2%) were people over 60 years of age. There was a predominance of males with white skin color. The prescription of the Pneumococcal 23 vaccine was more prevalent among adolescents, adults, and the elderly (30.8%, 34.9%, and 63.6%, respectively).
Conclusion:
This study analyzed the clinical and epidemiological profile of patients treated at the Reference Center for Special Immunobiologicals in Minas Gerais over a period of 17 years. The characterization of users and prescribed immunobiologicals made it possible to identify this profile, highlighting the relevance of the service.
